EVALUATION OF TROUGH LEVEL AND DISEASE ACTIVITY AFTER SWITCH FROM ADALIMUMAB ORIGINATOR TO BIOSIMILAR IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Nele Deprez  1     Mieke Deceuninck  2     Didier Baert  1     Thomas De Somer  1     Inge Huys  1     Veerle Mattens  3     An Sterckx  3     Stijn Vanden Branden  3     Erik Vanderstraeten  4     Nina Van Heddegem     Pieter Dewint     Jo Vandervoort    
1 AZ Maria Middelares Gent,Gent,Belgium
2 Sint Vincentius Ziekenhuis Deinze,Deinze,Belgium
3 OLV Ziekenhuis Aalst,Aalst,Belgium
4 AZ Maria Middelares

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing